Lincoln Pharmaceuticals Ltd has announced that the Board of Directors of the Company at its meeting held on July 21, 2008, inter alia, has issued one crore warrants convertible into Equity shares of Rs 2/- each at a premium of Rs 8/- per share to promoters and non promoters group parties pursuant to "in-principal" approval received from stock exchange.